1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. PharmaCyte Biotech Inc (PMCB)
  7. Financials

PharmaCyte Biotech Inc. (PMCB) Fundamentals
PharmaCyte Biotech Inc is a clinical stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes will be developed. It is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer killing drugs at the source of cancer.
SHARE INFORMATION
Market Cap$ 47,036,777
Shares Outstanding20,721,047
Float20,667,345
Percent Float99.74%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -2.51
Latest Fiscal Date2021-04-30
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions4
Institutional Holdings Date2021-08-31
Institutional Bought Previous 3 Months57
Institutional Holdings Percent0.0%
Institutional Sold Previous 3 Months-
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months-
Insider Holdings Percent2.8
Insider Sold Previous 3 Months-
Insider Shares Owned589,400
TRADING INFO
52 Week High$ 21.45
52 Week Low$ 1.79
52 Week High Change$ -87.89
21 Day Moving Average$ 2.1995
21 Day Extended Moving Average$ 2.2104
50 Day Moving Average$ 2.2216
50 Day Extended Moving Average$ 2.2213
200 Day Moving Average$ 2.7171
200 Day Extended Moving Average$ 5.0412
10 Day Average Volume168,042
20 Day Average Volume235,537
30 Day Average Volume711,703
50 Day Average Volume463,905
Alpha-0.019272
Beta-0.0228
Standard Deviation0.321782
R20.000011
7 Day Price Change$ 0.20
7 Day Percent Change9.66%
21 Day Price Change$ 0.04
21 Day Percent Change1.79%
30 Day Price Change$ 0.25
30 Day Percent Change12.38%
Month to Date Price Change$ -0.06
Month to Date Percent Change-2.58%
Quarter to Date Price Change$ -0.03
Quarter to Date Percent Change-1.3%
180 Day Price Change$ -0.34
180 Day Percent Change-13.03%
200 Day Price Change$ -0.55
200 Day Percent Change-19.5%
Year to Date Price Change$ -0.23
Year to Date Percent Change-9.2%

PharmaCyte Biotech Inc. (PMCB) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.50
Total Debt To Equity0.00
Int Coverage-2,437.00
Current Ratio141.60
Leverage Ratio1.00
Quick Ratio141.30
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-1.70
Enterprise Value$ 43,606,584
Price to Sales0.00
Price to Free Cash-15.90
PE High Last 5 Years-9.50
Price To Book0.50
Price To Cash Flow0.00
PE Low Last 5 Years-6.30
Price to Tangible Book0.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-7.58
Return on Equity-7.68
Return on Capital-7.63

PharmaCyte Biotech Inc. (PMCB) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorArmanino LLP
CEOKenneth L. Waggoner
Emplyoees4
Last AuditUQ
CIK0001157075
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address23046 Avenida de la Carlota
Suite 600
Laguna Hills, CA 92653
Websitehttps://www.pharmacyte.com
Facsimile+1 917 595-2851
Telephone+1 917 595-2850
Emailinfo@PharmaCyteBiotech.com


Your Recent History
NASDAQ
PMCB
PharmaCyte..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.